KIAA0280 Activators
KIAA0280 Activators encompass a range of chemical compounds that indirectly amplify the functional activity of KIAA0280 via assorted signaling pathways. Forskolin, by raising intracellular cAMP, activates protein kinase A, which may phosphorylate proteins that interact with KIAA0280, thereby enhancing its activity. Similarly, the cAMP analog 8-Bromo-cAMP directly activates PKA, leading to the modulation of KIAA0280 activity through PKA-dependent phosphorylation. Ionomycin, by elevating intracellular calcium levels, influences calcium-dependent kinases and proteins, potentially affecting KIAA0280 through these calcium-signaling cascades. IBMX, which inhibits the breakdown of cAMP and cGMP, can indirectly activate KIAA0280 by stimulating PKA and PKG pathways that interact with KIAA0280's signaling network. Phorbol 12-myristate 13-acetate (PMA), through PKC activation, and Bisindolylmaleimide I, despite being a PKC inhibitor, could both impact KIAA0280's phosphorylation state and activity by altering the balance of protein kinases within the cell, highlighting the complex interplay of kinase signaling in regulating KIAA0280.
Additionally, the modulation of protein phosphorylation states plays a crucial role in the activation of KIAA0280. Okadaic acid and Calyculin A, inhibitors of protein phosphatases PP1 and PP2A, enhance KIAA0280 by maintaining a phosphorylated state of proteins within its signaling pathways. Anisomycin, which activates stress-activated protein kinases, could similarly enhance KIAA0280 activity by altering the phosphorylation landscape. KN-93's inhibition of CaMKII and Cyclopiazonic acid's inhibition of SERCA both result in changes to calcium signaling dynamics that could facilitate the activation of KIAA0280 through alternative signaling routes. Furthermore, Epigallocatechin gallate (EGCG) modulates the activity of kinases and phosphatases, offering another potential avenue for the enhancement of KIAA0280 through intricate signaling networks. Collectively, these KIAA0280 Activators work through a diverse set of biochemical mechanisms, ultimately leading to the enhanced functional activity of KIAA0280 without directly altering its expression levels.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC) which phosphorylates serine and threonine residues on various proteins. PKC-mediated phosphorylation can influence KIAA0280 activity by altering the phosphorylation state of proteins within signaling pathways that KIAA0280 is involved in. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, activating calcium-dependent signaling pathways. This can enhance KIAA0280 activity by affecting calcium-binding proteins or calcium-dependent kinases that are part of the signaling cascades associated with KIAA0280's function. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
8-Bromo-cAMP is a cell-permeable analog of cAMP that activates PKA. By mimicking cAMP, it can lead to the activation of KIAA0280 through PKA-dependent phosphorylation events that modulate proteins interacting with KIAA0280. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a nonspecific inhibitor of phosphodiesterases, which prevents the breakdown of cAMP and cGMP, leading to increased levels of these signaling molecules. This can enhance the activity of KIAA0280 by stimulating PKA or PKG pathways that indirectly modulate KIAA0280's activity. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is an inhibitor of protein phosphatases PP1 and PP2A, leading to an increase in protein phosphorylation. By preventing dephosphorylation, it indirectly enhances the activity of KIAA0280 by maintaining the phosphorylation state of proteins within KIAA0280-associated signaling pathways. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Similar to okadaic acid, Calyculin A is an inhibitor of protein phosphatases PP1 and PP2A. It indirectly enhances KIAA0280 activity by increasing the phosphorylation levels of proteins that may interact with or regulate KIAA0280. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that also activates stress-activated protein kinases such as JNK and p38 MAPK. Activation of these kinases could enhance KIAA0280 activity by modifying the phosphorylation state of proteins within KIAA0280's signaling network. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I is a selective PKC inhibitor that can paradoxically enhance KIAA0280 activity by shifting the balance of kinase activity within the cell, potentially favoring the activation of alternate pathways that KIAA0280 is a part of. | ||||||